← Back to Screener
SeaStar Medical Holding Corporation Warrant (ICUCW)
Price$0.02
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-39.80%
Price vs S&P 500 (4W)-12.64%
VGM Score32.01
All Metrics
Price vs S&P 500 (YTD)55.31%
10-Day Avg Trading Volume0.01M
3-Month Avg Trading Volume0.04M
52-Week High$0.05
26-Week Price Return-24.70%
13-Week Price Return-32.36%
3-Month Return Std Dev102.27%
Year-to-Date Return64.60%
5-Day Price Return0.54%
Month-to-Date Return17.72%
Price vs S&P 500 (13W)-42.94%
Beta0.78x
52-Week Low$0.01
mGradeD
vgmGradeD
Show chart for
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ICUCWSeaStar Medical Holding Corporation Warrant | — | — | D | $0.02 |
| SYKStryker Corporation | C | C | D | $295.00 |
| MMM3M Company | C | F | C | $151.65 |
| BSXBoston Scientific Corp. | C | B | F | $47.69 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.61 |
| MDLNMedline Inc. Class A common stock | B | D | D | $34.47 |
| DXCMDexCom, Inc. | C | B | C | $72.77 |
| RMDResMed Inc. | B | B | D | $186.46 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.31 |
| SOLVSolventum Corporation | C | D | C | $78.36 |
| PENPenumbra, Inc. | F | C | C | $319.37 |
About
SeaStar Medical Holding Corp develops extracorporeal therapies to reduce the effects of systemic hyperinflammation on vital organs. The company's proprietary technology targets immune cells responsible for driving inflammatory responses and tissue damage. SeaStar operates a single medical device business segment focused on treating hyperinflammation-related conditions.